132 related articles for article (PubMed ID: 19706818)
1. Complexity made simple in diffuse large B-cell lymphoma.
Aster J; Kutok J
Clin Cancer Res; 2009 Sep; 15(17):5291-3. PubMed ID: 19706818
[TBL] [Abstract][Full Text] [Related]
2. [Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].
Lin L; Min M; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):220-6. PubMed ID: 21615994
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system].
Min M; Lin L; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):110-6. PubMed ID: 22780928
[TBL] [Abstract][Full Text] [Related]
4. Correlation Analysis Between the Expression of MEF2B, and Germinal Center and Nongerminal Center Markers in Diffuse Large B-Cell Lymphoma.
Salama A; Marcellino BK; Saad AG; Teruya-Feldstein J; Firpo-Betancourt A; Abulsayen HA; Grada Z; Hassan M; El Jamal SM
Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):e63-e64. PubMed ID: 31850910
[No Abstract] [Full Text] [Related]
5. [Prevalence of germinal center B-cell-like and non-germinal center B-cell-like types of diffuse large B-cell lymphoma in Shanghai, China].
Chen Y; Chen H; Fu K; Zhu XZ; Irons R
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):313-8. PubMed ID: 20654154
[TBL] [Abstract][Full Text] [Related]
6. Genotypic and phenotypic differences between nodal and extranodal diffuse large B-Cell lymphomas.
Al-Humood SA; Al-Qallaf AS; Alshemmari SH; Francis IM; Junaid TA; Marouf RA; Al-Mulla F
J Histochem Cytochem; 2011 Oct; 59(10):918-31. PubMed ID: 21832150
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characterization of 61 cases of diffuse large B-cell lymphoma with different prognosis].
Wang Q; Wei XD; Yin QS
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):136-7. PubMed ID: 22780933
[No Abstract] [Full Text] [Related]
8. [Analysis of mutations in IgVH genes in diffuse large B-cell lymphomas].
Liang Y; Zhou R; Zhang W; Zhang HL; Xu HD; Mao ZR
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):625-6. PubMed ID: 18070454
[No Abstract] [Full Text] [Related]
9. Blimp-1 protein and Hans classification on prognosis of diffuse large B-cell lymphoma and their interrelation.
Song Y; Cao Z; Li L; Zhang HT; Zhang X
Chin J Cancer; 2010 Sep; 29(9):781-6. PubMed ID: 20800019
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical profile and fluorescence in situ hybridization analysis of diffuse large B-cell lymphoma in northern China.
Li T; Medeiros LJ; Lin P; Yin H; Littlejohn M; Im W; Lennon PA; Hu P; Jorgensen JL; Liang M; Guo H; Yin CC
Arch Pathol Lab Med; 2010 May; 134(5):759-65. PubMed ID: 20441508
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of CD-10, BCL-6 and MUM-1 antibodies and immediate clinical response in patients of diffuse large B-cell lymphomas after six cycles of chemotherapy.
Hassan U; Ishtiaq S; Hussain M
J Coll Physicians Surg Pak; 2014 Oct; 24(10):722-7. PubMed ID: 25327914
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis.
Bodoor K; Matalka I; Hayajneh R; Haddad Y; Gharaibeh W
Asian Pac J Cancer Prev; 2012; 13(7):3037-46. PubMed ID: 22994707
[TBL] [Abstract][Full Text] [Related]
13. [Subgrouping and outcome prediction of diffuse large B-cell lymphoma by immunohistochemistry].
Ye ZY; Cao YB; Lin TY; Lin HL
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):654-9. PubMed ID: 18194597
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients.
Culpin RE; Sieniawski M; Angus B; Menon GK; Proctor SJ; Milne P; McCabe K; Mainou-Fowler T
Histopathology; 2013 Dec; 63(6):788-801. PubMed ID: 24117687
[TBL] [Abstract][Full Text] [Related]
15. Determination of the molecular subtypes of diffuse large B-cell lymphomas using immunohistochemistry: a case series from the Inselspital, Bern, and a critical appraisal of this determination in Switzerland.
Reber R; Banz Y; Garamvölgyi E; Perren A; Novak U
Swiss Med Wkly; 2013; 143():w13748. PubMed ID: 23740154
[TBL] [Abstract][Full Text] [Related]
16. Cancer: negative feedback for B cells.
Staudt LM
Nature; 2004 Oct; 431(7011):919-20. PubMed ID: 15496906
[No Abstract] [Full Text] [Related]
17. [Prognosticators for diffuse B-large cell lymphoma].
Bogdanov AN; Ignat'ev SB; Kamilova TA
Vopr Onkol; 2008; 54(2):133-41. PubMed ID: 18522160
[No Abstract] [Full Text] [Related]
18. Clinical relevance of CD10, BCL-6 and multiple myeloma-1 expression in diffuse large B-cell lymphomas in Malaysia.
Peh SC; Gan GG; Lee LK; Eow GI
Pathol Int; 2008 Sep; 58(9):572-9. PubMed ID: 18801072
[TBL] [Abstract][Full Text] [Related]
19. Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells?
de Leval L; Ferry JA; Falini B; Shipp M; Harris NL
Am J Surg Pathol; 2001 Oct; 25(10):1277-82. PubMed ID: 11688462
[TBL] [Abstract][Full Text] [Related]
20. Prognostic evaluation of immunohistochemical profiles in diffuse large B-cell lymphoma: a Chinese study.
Chen Z; Du Z; Chen J; Chen Z; Bao Y; Tang F
Med Oncol; 2011 Mar; 28(1):241-8. PubMed ID: 20165991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
